Overexpressed Wnt-7a acts as a potential antitumor immune modulator and predicts poor prognosis in HNSCC
Immune checkpoint inhibitor (ICI) has become the first-line treatment of advanced head and neck squamous cell carcinoma (HNSCC), which has a relatively poor clinical prognosis and high mortality. However, only a proportion of patients respond well to ICI therapy. Identifying reliable predictive mark...
Saved in:
| Main Authors: | Hui-chao Jiang, Ya Gao, Shu-yan Wang, Yong-lan Zhao, Hai-peng Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025011752 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune-metabolic crosstalk in HNSCC: mechanisms and therapeutic opportunities
by: Xiyuan Qin, et al.
Published: (2025-05-01) -
From pathogen to cure: exploring the antitumor potential of Toxoplasma gondii
by: Parisa Alipanahi, et al.
Published: (2025-06-01) -
PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1
by: Lvyun Zhu, et al.
Published: (2024-12-01) -
The role of the tumor microenvironment in HNSCC resistance and targeted therapy
by: Zhaomeng Guo, et al.
Published: (2025-04-01) -
The use of xenogenic testicular antigens for induction of antitumor reactions
by: G. V. Seledtsova, et al.
Published: (2024-01-01)